Menu Philippe 4

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on May 26, 2026 in open-market transactions for a total of approximately $24,774. The reported weighted-average price was $4.95 per share (individual trades ranged from $4.78 to $5.01). This was a sale (routine liquidity) rather than a purchase.

Key Details

• Transaction date: 2026-05-26. Filed with the SEC on 2026-06-01 (appears later than the typical 2-business-day Form 4 deadline).
• Shares sold: 5,000; weighted-average price: $4.95; total proceeds reported: $24,774.
• Price range: trades occurred at prices from $4.78 to $5.01 (footnote says breakdown by price available on request).
• Footnotes: F1 — sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan; F2 — weighted-average price with multiple execution prices and offer to provide per-price breakdown.
• Shares owned after the transaction: not disclosed in the provided filing excerpt.

Context
Sales made under a 10b5-1 plan are pre-planned transactions that can reflect scheduled liquidity or diversification and are generally considered less indicative of new insider sentiment about the company. This report shows a routine disposition rather than an acquisition or option exercise.